1. Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial. Issue 6 (June 2020) Authors: Dooley, Kelly E; Savic, Radojkam; Gupte, Akshay; Marzinke, Mark A; Zhang, Nan; Edward, Vinodh A; Wolf, Lisa; Sebe, Modulakgotla; Likoti, Morongwe; Fyvie, Mark J; Shibambo, Innocent; Beattie, Trevor; Chaisson, Richard E; Churchyard, Gavin J Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗